{"id":15016,"date":"2016-10-31T16:11:21","date_gmt":"2016-10-31T20:11:21","guid":{"rendered":"http:\/\/www.aidslaw.ca\/site\/?p=15016"},"modified":"2022-09-25T21:46:23","modified_gmt":"2022-09-26T01:46:23","slug":"brief-to-the-house-of-commons-standing-committee-on-international-trade-on-the-trans-pacific-partnership","status":"publish","type":"publication22","link":"https:\/\/www.hivlegalnetwork.ca\/site\/brief-to-the-house-of-commons-standing-committee-on-international-trade-on-the-trans-pacific-partnership\/","title":{"rendered":"Brief to the House of Commons Standing Committee on International Trade on the Trans-Pacific Partnership"},"content":{"rendered":"&#8221;The Canadian HIV\/AIDS Legal Network welcomes this opportunity to provide submissions to the House of Commons Standing Committee on International Trade on the subject of the Trans-Pacific Partnership (TPP).&#8221;<\/p>\n<p>In the brief <em>The Trans-Pacific Partnership: Trading Away Access to Affordable Medicines<\/em>, we\u00a0&#8220;set out\u00a0[&#8230;] a number of specific concerns about how provisions in the TPP will undermine equitable access to affordable medicines, particularly:<br \/>\n(i) the stricter rules on intellectual property protection;<br \/>\n(ii) the deal\u2019s impact on drug formulary prices and weakening of controls on drug company marketing; and<br \/>\n(iii) the expanded rules for corporations to sue governments for regulating in the public interest under the investor-state dispute settlement clause.&#8221;<\/p>\n<p class=\"download-link-button\"><a class=\"download-link en\" title=\"Brief to the House of Commons Standing Committee on International Trade on the Trans-Pacific Partnership\" href=\"https:\/\/www.hivlegalnetwork.ca\/site\/download\/15013\/?tmstv=1776231631\" rel=\"nofollow\">\r\n\tDownload<\/a><\/p>","protected":false},"author":1,"featured_media":0,"menu_order":0,"template":"","meta":{"_acf_changed":false,"footnotes":""},"publication_topics":[145],"publication_type":[170],"publication_language":[184],"class_list":["post-15016","publication22","type-publication22","status-publish","hentry","publication_topics-access-to-medicines","publication_type-advocacy","publication_language-english"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/15016","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22"}],"about":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/types\/publication22"}],"author":[{"embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":3,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/15016\/revisions"}],"predecessor-version":[{"id":21640,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/15016\/revisions\/21640"}],"wp:attachment":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/media?parent=15016"}],"wp:term":[{"taxonomy":"publication_topics","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_topics?post=15016"},{"taxonomy":"publication_type","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_type?post=15016"},{"taxonomy":"publication_language","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_language?post=15016"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}